NCT05801198View on ClinicalTrials.gov

Addressing Asymptomatic Plasmodium Reservoirs to Accelerate Malaria Elimination and Eradication in Rwanda.

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

125

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

December 31, 2026

Conditions

Malaria,Falciparum

Interventions

DIETARY_SUPPLEMENT

Artemisia afra or Annua 10g oral infusion/tea per day for 14 days

Participants will be recruited after completing standard malaria treatment, and those who have a positive qRT-PCR for plasmodium gametocyte reservoirs will be randomly assigned to either artemisia afra tea, or artemisia annua tea or into the control group with no intervention

All Listed Sponsors

lead

King Faisal Hospital Rwanda

OTHER